Aminov Erez

Chief Executive Officer, DirectorMIRA PHARMACEUTICALS, INC. (MIRA) · full profile →Form 4 · filed May 22, 2024
Net Buying
Open-Market Buys
$8K
Open-Market Sells
$0
Net Open-Market Flow
$8K
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 21, 2024Buy(P)600$0.87$522381K
May 21, 2024Buy(P)800$1.01$808381K
May 21, 2024Buy(P)2K$1.00$2K376K
May 21, 2024Buy(P)500$1.02$510377K
May 21, 2024Buy(P)1K$1.03$1K377K
May 21, 2024Buy(P)800$0.97$776382K
May 21, 2024Buy(P)2K$0.84$2K379K
May 21, 2024Buy(P)1K$0.85$850380K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-021069) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about MIRA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001493152-24-021069"
Ask your agent
Use Arkolith to summarize insider buying and selling at MIRA PHARMACEUTICALS, INC.
over the last 90 days and cite the filings.